ZEISS Group

Medicinal Chemist (f/m/x)

ZEISS Group  •  Munich, DE (Onsite)  •  8 days ago
Apply
AI can make mistakes so check important info. Chat history is never stored.

Job Description

Your Role

  • Designing and developing molecular probes, including the linker components.

  • Collaborating with cell biologists, engineers and application experts to define probe requirements and performance specifications.

  • Conducting and interpreting in vitro studies (e.g. binding, selectivity, stability) to optimize probe performance;

  • Supporting further evaluation in collaboration with internal and external partners

  • Identifying and assessing project risks and developing mitigation strategies.

  • Troubleshooting and resolving technical issues related to linker chemistry, stability, and assay compatibility.

  • Keeping up to date of industry and academic trends in targeted probe technologies.

  • Documenting results clearly and reporting on project progress to management and stakeholders.

Your Profile

  • PhD in medicinal chemistry, organic chemistry, chemical biology or a comparable discipline.

  • At least 2 years of professional experience in drug-like small molecule design, bioconjugation, or targeted probe development in an industrial or start up environment.

  • Demonstrated expertise in: Design and synthesis of small molecules and linkers. Conjugation strategies for proteins or antibodies. Biophysical and biochemical characterization of conjugates

  • Familiarity with in vitro assay data and their use in property optimization; experience interfacing with in vivo studies is a plus.

  • Excellent communication skills and enjoyment of working in interdisciplinary, cross functional teams.

  • Very good written and spoken English skills; German and Chinese are a plus.

Your ZEISS Recruiting Team:

Friederike Kirklar-Harms

ZEISS Group

About ZEISS Group

ZEISS is an internationally leading technology enterprise operating in the fields of optics and optoelectronics. In the previous fiscal year, the ZEISS Group generated annual revenue around 11 billion euros in its four segments Semiconductor Manufacturing Technology, Industrial Quality & Research, Medical Technology and Consumer Markets (30 September 2024).

With over 46,000 employees, ZEISS is active globally in around 50 countries with more than 60 sales and service locations, around 40 research and development facilities, and 35 production facilities worldwide (30 September 2024). Founded in 1846 in Jena, the company is headquartered in Oberkochen, Germany. The Carl Zeiss Foundation, one of the largest foundations in Germany committed to the promotion of science, is the sole owner of the holding company, Carl Zeiss AG.

Data privacy: www.zeiss.com/data-protection

Imprint: http://zeiss.com/publisher

This is ZEISS's official LinkedIn account. It follows the ZEISS Netiquette: www.zeiss.com/netiquette

Industry
Manufacturing & Production
Company Size
10,000+ employees
Headquarters
Oberkochen, DE
Year Founded
1846
Website
zeiss.com
Social Media